Globus Medical Stock Fundamentals

GMED Stock  USD 53.64  0.58  1.09%   
Globus Medical fundamentals help investors to digest information that contributes to Globus Medical's financial success or failures. It also enables traders to predict the movement of Globus Stock. The fundamental analysis module provides a way to measure Globus Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Globus Medical stock.
At present, Globus Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.6 B, whereas EBIT is forecasted to decline to about 168.5 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Globus Debt To Equity Analysis

Globus Medical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
 2021 2022 2023 2024 (projected)
Gross Profit718.9M759.1M1.0B533.4M
Total Revenue958.1M1.0B1.6B1.6B

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Globus Medical Debt To Equity

    
  0 %  
Most of Globus Medical's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Globus Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

Globus Total Stockholder Equity

Total Stockholder Equity

4.2 Billion

At present, Globus Medical's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.
According to the company disclosure, Globus Medical has a Debt To Equity of 0.002%. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.

Globus Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Globus Medical's current stock value. Our valuation model uses many indicators to compare Globus Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Globus Medical competition to find correlations between indicators driving Globus Medical's intrinsic value. More Info.
Globus Medical is rated as one of the top companies in revenue category among related companies. It is one of the top stocks in net income category among related companies making up about  0.08  of Net Income per Revenue. The ratio of Revenue to Net Income for Globus Medical is roughly  12.77 . At present, Globus Medical's Net Income is projected to increase significantly based on the last few years of reporting.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Globus Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Globus Medical's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Globus Medical's earnings, one of the primary drivers of an investment's value.

Globus Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Globus Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Globus Medical could also be used in its relative valuation, which is a method of valuing Globus Medical by comparing valuation metrics of similar companies.
Globus Medical is currently under evaluation in profit margin category among related companies.

Globus Fundamentals

About Globus Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Globus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Globus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Globus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Current Deferred Revenue18.4 M9.6 M
Total Revenue1.6 B1.6 B
Cost Of Revenue548.2 M575.6 M
Ebit Per Revenue 0.08  0.08 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Globus Medical Piotroski F Score and Globus Medical Altman Z Score analysis.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.